KRAS and non-small cell lung carcinoma: TNF-α and its receptors are widely expressed in NSCLC; however epidermal growth factor receptor and KRAS oncogenic mutations are specifically enriched in LUAD compared with LUSC (49), which may contribute to the higher ERVK-7.long expression in LUAD.